Skip to main content

Table 5 Availability of malaria commodities in the private sector

From: The malaria testing and treatment landscape in Kenya: results from a nationally representative survey among the public and private sector in 2016

  Private For-Profit Facility Registered pharmacy Unregistered pharmacy General retailer Total private sector
% (95% CI) % (95% CI) % (95% CI) % (95% CI) % (95% CI)
Availability of anti-malarials among all screened outlets N = 360 N = 145 N = 493 N = 14,204 N = 15,202
 Any anti-malarial 76.4 93.3 87.2 2.4 7.1
(70.4, 81.4) (87.8, 96.5) (82.8, 90.6) (1.7, 3.5) (6.4, 7.9)
Availability of anti-malarials among anti-malarial-stocking outlets N = 280 N = 134 N = 428 N = 244 N = 1086
 QAACT 59.3 73.2 64.3 9.9 46.7
(51.2, 67.0) (65.6, 79.7) (58.6, 69.7) (5.1, 18.4) (39.4, 54.1)
 Non-QAACT 52.3 76.8 48.5 3.0 37.9
(44.6, 59.9) (68.7, 83.3) (41.4, 55.6) (1.3, 6.8) (31.5, 44.7)
 SP 25.6 49.9 55.2 85.2 57.6
(19.5, 32.9) (38.9, 61.0) (47.1, 63.0) (75.1, 91.6) (50.8, 64.0)
 Any non-artemisinin therapy 50.3 57.2 68.7 88.5 69.6
(42.8, 57.8) (45.1, 68.4) (60.6, 75.8) (78.9, 94.1) (63.2, 75.4)
 Artesunate injection 10.1 1.7 1.2 0.0 2.9
(5.9, 16.8) (0.5, 5.6) (0.5, 2.6) (1.7, 4.7)
Availability of blood testing among anti-malarial-stocking outletsa N = 307 N = 138 N = 467 N = 310 N = 1222
 Any diagnostic test 66.9 22.4 12.1 0.2 20.8
(59.2, 73.8) (16.4, 29.8) (9.1, 16.0) (0.0, 1.4) (16.5, 25.8)
 Malaria microscopy 48.1 8.8 3.2 0.0 12.4
(39.1, 57.3) (5.0, 15.1) (2.0, 5.3) (9.1, 16.7)
 RDT 36.0 16.0 9.5 0.2 12.6
(30.2, 42.3) (11.1, 22.5) (7.0, 13.0) (0.0, 1.4) (10.0, 15.8)
  1. Among outlets stocking anti-malarials todays or within the past 3 months